Neurogene Inc (NGNE)
followers
·
Follow
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Jonathan G. Drachman
Employees:
90
SUITE 360 - 1616 EASTLAKE AVE EAST SEATTLE WA 98102
206-732-2133
-
Formally known as:
- NEOLEUKIN THERAPEUTICS ORD SHS
Date | Ratio |
---|---|
2023-09-25 | 1:5 |
2023-12-19 | 1:4 |
Neoleukin Therapeutics, Inc. develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma.
All 13F Filers | Prior | Change | Hedge Funds 1 | Prior | Change |
---|